Riskpilot← Back to searchSign inGet full accessHAMAR FYSIOTERAPI AS
ASActiveOrg 926489828Vangsvegen 62, 2317 HamarPhysiotherapy activities · NACE 8695Est. 20211 employees
Revenue 2025
NOK 1,4M
+2% vs 2024
EBITDA margin
9.0%
-6% vs 2024
Equity ratio
40.6%
Financial strength
Net profit 2025
NOK 8
-97% vs 2024
| Revenue | NOK 1,4M | +2% |
| EBITDA | NOK 127K | -6% |
| Net profit | NOK 8 | -97% |
| Total assets | NOK 740K | -11% |
| Equity | NOK 300K | +0% |
| Employees | 1 | — |
Legal name
HAMAR FYSIOTERAPI AS
Org number
926489828
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
29. januar 2021
Share capital
NOK 300 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap.
Company purpose
Å være driftsselskap for interessentskapet hamar fysioterapi slik dette behov til enhver tid måtte være.
Address
Vangsvegen 62, 2317 Hamar
Phone
+4762530440
Email
aaste@hamarfysioterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 053 | 1 607 | 1 454 | 1 396 | 1 420 |
| Staff expenses | −388 | −513 | −306 | −218 | −225 |
| EBITDA | 75 | 128 | 140 | 135 | 127 |
| Depreciation & amort. | −44 | −90 | −96 | −98 | −99 |
| EBIT | 31 | 38 | 44 | 37 | 28 |
| Net financials | −32 | −35 | −40 | −37 | −28 |
| Profit before tax | −1 | 3 | 4 | 0 | 0 |
| Tax | −0 | −0 | −0 | 0 | 0 |
| Net profit | −1 | 3 | 4 | 0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 170 | 1 320 | 971 | 833 | 740 |
| Equity | 293 | 296 | 300 | 300 | 300 |
| Long-term debt | 633 | 533 | 433 | 333 | 233 |
| Short-term debt | 243 | 491 | 238 | 200 | 206 |
| Total debt | 877 | 1 024 | 671 | 533 | 439 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20212025
Equity ratio
40.6%
This company
38.2%
Market median
+6% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
1.92×
This company
1.12×
Market median
+71% vs market
20212025
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-11 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HAMAR FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnhild Hagen | Board of Directors | 0 companies |